128 related articles for article (PubMed ID: 2632726)
1. Suppression of cerebral, myocardial and renal arteriosclerosis by the calcium antagonist flunarizine in hypertensive rats (Skelton model) without reduction of the high blood pressure.
Schwabedal PE; Brügging-Schmitz G; Oestreich W; Szathmary SC
J Hypertens Suppl; 1989 Dec; 7(6):S280-1. PubMed ID: 2632726
[No Abstract] [Full Text] [Related]
2. [The clinical instrumental evaluation of treatment efficacy in patients with concomitant atherosclerosis of the coronary, cerebral and peripheral arteries].
Karpov RS; Dudko VA; Shipulin VM; Kanskaia NV; Koshel'skaia OA; Stepanian NA; Fedorova NA; Balabanova AV
Ter Arkh; 1991; 63(4):90-3. PubMed ID: 2068687
[TBL] [Abstract][Full Text] [Related]
3. [Suppression of coronary sclerosis in hypertensive rats by calcium channel antagonists without lowering blood pressure].
Schwabedal PE; Oestreich W; Szathmary SC
Z Kardiol; 1989; 78 Suppl 5():108-11. PubMed ID: 2534340
[TBL] [Abstract][Full Text] [Related]
4. [Nervous disease & Ca antagonist].
Otomo E
No To Shinkei; 1990 Jan; 42(1):33-41. PubMed ID: 2337488
[No Abstract] [Full Text] [Related]
5. [Effect of kavinton on the hemodynamics and adenosine metabolism in atherosclerosis patients].
Mikunis RI; Serkova VK; Zhebel' VN
Vrach Delo; 1988 Jul; (7):27-9. PubMed ID: 3188457
[No Abstract] [Full Text] [Related]
6. [Non-invasive diagnosis and medical therapy of cerebral and/or peripheral atherosclerotic vasculopathies].
Rezzo R; Stabilini L; Bertoglio C; Ruben G; De Gregori M; Fontana G; Gori A; Petrilli GL
Clin Ter; 1984 Dec; 111(6):495-511. PubMed ID: 6396028
[No Abstract] [Full Text] [Related]
7. Quantitative assessment of coronary arteriosclerosis in hypertensive rats.
Schwabedal PE
Cardiology; 1995; 86(3):224-31. PubMed ID: 7614495
[TBL] [Abstract][Full Text] [Related]
8. Comparison of effects of ACE inhibition with calcium channel blockade on renal disease in a model combining genetic hypertension and diabetes.
Rumble JR; Doyle AE; Cooper ME
Am J Hypertens; 1995 Jan; 8(1):53-7. PubMed ID: 7734098
[TBL] [Abstract][Full Text] [Related]
9. A preliminary investigation of Tanakan in the treatment of hypertensive arteriosclerosis and stroke in rats.
Fang Y; Huang R; Zhang Y; Lin J; Li J
Chin Med J (Engl); 2000 May; 113(5):425-8. PubMed ID: 11776097
[TBL] [Abstract][Full Text] [Related]
10. Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.
Jovanovic D; Jovovic D; Mihailovic-Stanojevic N; Miloradovic Z; Naumovic R; Dimitrijevic J; Maksic N; Djukanovic L
Biomed Pharmacother; 2009 Sep; 63(8):571-6. PubMed ID: 19013753
[TBL] [Abstract][Full Text] [Related]
11. [Use of recordil-30 in arteriosclerosis of the arteries of the heart, brain and lower extremities].
Zadionchenko VS; Savenkov PM; Martynov AI
Kardiologiia; 1974 Apr; 14(4):108-12. PubMed ID: 4836803
[No Abstract] [Full Text] [Related]
12. Chronic administration of oral vasopressin type 2 receptor antagonist tolvaptan exerts both myocardial and renal protective effects in rats with hypertensive heart failure.
Morooka H; Iwanaga Y; Tamaki Y; Takase T; Akahoshi Y; Nakano Y; Fujiki H; Miyazaki S
Circ Heart Fail; 2012 Jul; 5(4):484-92. PubMed ID: 22628529
[TBL] [Abstract][Full Text] [Related]
13. [Clinical use of a new vasoactive drug : nicergoline].
Mellini M
Minerva Med; 1973 May; 64(34):1844-53. PubMed ID: 4719381
[No Abstract] [Full Text] [Related]
14. Protective effect of flunarizine on blood-brain barrier permeability alterations in acutely hypertensive rats.
Nag S
Stroke; 1991 Oct; 22(10):1265-9. PubMed ID: 1926237
[TBL] [Abstract][Full Text] [Related]
15. Symptomatic Intracranial Atherosclerosis With Impaired Distal Perfusion: A Case Study.
Dakay K; Yaghi S
Stroke; 2018 Jan; 49(1):e10-e13. PubMed ID: 29167389
[No Abstract] [Full Text] [Related]
16. [Therapy of arteriosclerotic vasculopathies with arterial wall extract].
Veccia F
Clin Ter; 1967 Sep; 42(5):429-42. PubMed ID: 5617689
[No Abstract] [Full Text] [Related]
17. [Comparative study of the fibrinolytic activity of dimethylbiguanide in prevention of thromboembolism in patients with angiocardiopathy].
Molino N; Belluardo C
Rass Int Clin Ter; 1968 Jun; 48(11):687-700. PubMed ID: 5738544
[No Abstract] [Full Text] [Related]
18. Nephroangiosclerosis and its pharmacological approach.
Cianci R; Barbano B; Martina P; Gigante A; Polidori L; Lai S; Ascoli G; De Francesco I; Di Donato D; Fuiano G; Zuccalà A
Curr Vasc Pharmacol; 2011 Mar; 9(2):238-43. PubMed ID: 20507278
[TBL] [Abstract][Full Text] [Related]
19. [On the pathogenesis of sympatho-adrenal dysfunction in cerebral and cardiac manifestations of hypertensive disease and atherosclerosis].
Savenko SN; Vladkovskiĭ IK; Maĭdanik FE
Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(3):391-6. PubMed ID: 5658305
[No Abstract] [Full Text] [Related]
20. [Clinical experiences with the vascular action of dihydroergocristine].
Tomasi AM; Baggioni GF; Pozzar C
Minerva Cardioangiol; 1975 Jan; 23(1):7-19. PubMed ID: 806854
[No Abstract] [Full Text] [Related]
[Next] [New Search]
